AFFLUENT MEDICAL |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.74 EUR | +0.58% |
|
-3.33% | -5.69% |
| Apr. 25 | Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 13 | AFFLUENT MEDICAL : Invest Securities reiterates its opinion | CF |
| Sales 2023 | - | Sales 2024 * | - | Capitalization | 57.07M 53.28M |
|---|---|---|---|---|---|
| Net income 2023 | -15M -14M | Net income 2024 * | -20M -18.67M | EV / Sales 2023 | - |
| Net Debt 2023 * | 10.73M 10.02M | Net Debt 2024 * | 29.78M 27.81M | EV / Sales 2024 * | - |
| P/E ratio 2023 * |
-3.06
x | P/E ratio 2024 * |
-3.26
x | Employees | 52 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 29.65% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +0.58% | ||
| 1 week | -3.33% | ||
| Current month | -0.29% | ||
| 1 month | -0.57% | ||
| 3 months | +3.26% | ||
| 6 months | +45.00% | ||
| Current year | -5.69% |
1 week
1.72
1.80
1 month
1.712.06
Current year
1.232.13
1 year
0.932.30
3 years
0.938.60
5 years
0.938.60
10 years
0.938.60
| Managers | Title | Age | Since |
|---|---|---|---|
Sébastien Ladet
CEO | Chief Executive Officer | - | 22-08-21 |
Luc Parisot
DFI | Director of Finance/CFO | - | - |
Benjamin Renault
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 65 | 18-03-26 | |
| Director/Board Member | - | 18-03-26 | |
| Director/Board Member | - | 22-01-18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 1.74 | +0.58% | 2 585 |
| 24-04-26 | 1.73 | -1.70% | 2,169 |
| 24-04-25 | 1.76 | +1.15% | 767 |
| 24-04-24 | 1.74 | -1.14% | 2,150 |
| 24-04-23 | 1.76 | -2.22% | 3,889 |
Real-time Euronext Paris, April 29, 2024 at 07:47 am EDT
More quotes
Affluent Medical is specialized in the development and production of mini-invasive prostheses used for treating heart disease and urinary incontinence.
Calendar
2024-09-25
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.73
EUR
Average target price
3.367
EUR
Spread / Average Target
+94.61%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.69% | 57.07M | |
| +73.17% | 12.38B | |
| -18.74% | 7.92B | |
| +16.15% | 7.2B | |
| +6.73% | 5.84B | |
| +5.99% | 5.07B | |
| +27.07% | 4.53B | |
| -21.67% | 3.88B | |
| -40.82% | 2.23B | |
| +1.36% | 2.02B |
- Stock Market
- Equities
- AFME Stock
